Nutex Health Inc (NUTX)

Nutex Health Inc. is a Houston, Texas-based healthcare services and operations company founded in 2011 and listed on NASDAQ as common stock. The company operates in the United States through three segments. Its Hospital segment develops and runs micro hospitals, specialty hospitals, and hospital outpatient departments, providing services such as emergency care, inpatient treatment, behavioral health, imaging, laboratory testing, and onsite inpatient pharmacy support. The Population Health Management segment supports affiliated hospitals and physician groups through administrative and management services, provider network development, independent physician associations, and a cloud-based platform for IPAs. The Real Estate segment owns and leases land and hospital facilities.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-NUTX
$266.92
27.8% Upside
Undervalued
$283
35.5% Upside
Undervalued
Excellent
0.0%
November 24, 2026
7.9x
3.6x
1.7x
1.43 B
1.685 B
18.0%
60.5%
4.9
151.1%
Valuation • Fair Value

Nutex Health Inc (NASDAQ-NUTX) Fair Value by Valuation Model

Review the available estimates for Nutex Health Inc (NASDAQ-NUTX), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$266.92

Estimated upside of 27.8% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$328.19

Discounted cash flow valuation reference.

Ben Graham Formula Value

$291.52

Classic Ben Graham valuation formula reference.

EPV Fair Value

$252.58

Earnings power value estimate.

Comps Fair Value

$208.05

Comparable-company valuation reference.

Analyst Price Target

$283

Analysts imply upside of 35.5%.

How to read these valuation models

Use the 7 available valuation references for Nutex Health Inc (NASDAQ-NUTX) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Nutex Health Inc (NASDAQ-NUTX)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

846.7 M

Current operating scale indicator.

Revenue Forecast

869.5 M

Forward revenue estimate.

EBITDA

502.3 M

Current operating profitability reference.

EBITDA Forecast

264.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Nutex Health Inc (NASDAQ-NUTX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Nutex Health Inc (NASDAQ-NUTX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Excellent

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.75

No elevated caution signal from this screen.

Altman Z-Score

4.9

Relatively strong balance-sheet zone.

FCF / Net Income

151.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Nutex Health Inc (NASDAQ-NUTX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Nutex Health Inc (NASDAQ-NUTX)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 24, 2026

Days to Earnings

67

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Nutex Health Inc (NASDAQ-NUTX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Nutex Health Inc (NASDAQ-NUTX) Stock Forecast & Technical Outlook

Review Nutex Health Inc (NASDAQ-NUTX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Nutex Health Inc (NASDAQ-NUTX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Nutex Health Inc (NASDAQ-NUTX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Nutex Health Inc (NASDAQ-NUTX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Nutex Health Inc (NASDAQ-NUTX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Nutex Health Inc (NASDAQ-NUTX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Nutex Health Inc (NASDAQ-NUTX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Nutex Health Inc (NASDAQ-NUTX) has a Strong Buy consensus, with 4 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 4
Hold 0
Sell 0
FAQ Fast Investor Answers

Nutex Health Inc (NASDAQ-NUTX) Stock FAQ

Data-supported answers about Nutex Health Inc (NASDAQ-NUTX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$266.92
Estimated upside 27.8%
Valuation Rating
Undervalued
Estimated upside of 27.8%
Analyst Target
$283
Implied upside 35.5%
Financial Health
Excellent
Current financial-health read

The current fair value estimate for Nutex Health Inc (NASDAQ-NUTX) is $266.92. This implies an estimated upside of 27.8% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 27.8% versus the current market price.

The available analyst price target for Nutex Health Inc (NASDAQ-NUTX) is $283. The analyst target implies estimated upside of 35.5%.

The current financial health read for Nutex Health Inc (NASDAQ-NUTX) is Excellent. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Nutex Health Inc (NASDAQ-NUTX) is November 24, 2026.

The latest available data indicates no current dividend yield for Nutex Health Inc (NASDAQ-NUTX).

The current P/E ratio listed for Nutex Health Inc (NASDAQ-NUTX) is 7.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Nutex Health Inc is 1.43 B.

The current enterprise value listed for Nutex Health Inc is 1.685 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Nutex Health Inc is NASDAQ-NUTX, and the stock is listed on NASDAQ.

Nutex Health Inc (NASDAQ-NUTX) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Nutex Health Inc is 18.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Nutex Health Inc is 60.5%. Free float helps investors understand how much of the share base is available for public trading.